| 9533978 |
Pyrimidine derivatives and their use in the treatment of cancer and further diseases |
Nicholas James Bennett, Stephen Thom |
2017-01-03 |
|
| 9045472 |
Imidazoquinoline compounds |
Austen Pimm |
2015-06-02 |
$35,533,000 |
| 8969362 |
9-substituted 8-oxoadenine compound |
Ayumu Kurimoto, Kazuki Hashimoto, Yoshiaki Isobe, Stephen Brough, Ian Millichip +2 more |
2015-03-03 |
$26,750,000 |
| 8895570 |
Purine derivatives |
Phillip G. Abbott, Roger Bonnert, Stephen Thom, Hiroki Wada, Satoshi Onuma |
2014-11-25 |
$25,833,000 |
| 8765939 |
Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers |
Nicholas James Bennett, Tobias Mochel, Stephen Thom, Anna-Karin Tiden |
2014-07-01 |
$74,173,000 |
| 8673907 |
Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
Hakan Schulz |
2014-03-18 |
$11,307,000 |
| 8575180 |
9-substituted 8-oxoadenine compound |
Ayumu Kurimoto, Kazuki Hashimoto, Yoshiaki Isobe, Stephen Brough, Ian Millichip +2 more |
2013-11-05 |
$11,856,000 |
| 8476288 |
Salts 756 |
Nicholas James Bennett, Austen Pimm, Yoshiaki Isobe |
2013-07-02 |
$6,797,000 |
| 8436178 |
Imidazoquinolines with immuno-modulating properties |
Roger Bonnert, Stephen Thom, Hiroki Wada |
2013-05-07 |
$7,216,000 |
| 8268990 |
Compounds |
Nicholas James Bennett, Stephen Thom |
2012-09-18 |
$6,569,000 |
| 8158820 |
Compounds |
Roger Bonnert, Stephen Brough, Andrew Davies, Timothy Jon Luker, Ian Millichip +4 more |
2012-04-17 |
$6,204,000 |
| 8067413 |
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators |
Roger Bonnert, Stephen Thom |
2011-11-29 |
$4,580,000 |
| 8067411 |
Compounds |
Roger Bonnert, Tobias Mochel, Stephen Thom |
2011-11-29 |
$4,580,000 |
| 8063051 |
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators |
Roger Bonnert, Stephen Thom |
2011-11-22 |
$3,731,000 |
| 8012964 |
9-substituted 8-oxoadenine compound |
Ayumu Kurimoto, Yoshiaki Isobe, Stephen Brough, Hiroki Wada, Roger Bonnert |
2011-09-06 |
$3,679,000 |
| 7358376 |
Substituted Thiophene compounds |
Andrew Baxter, Stephen Brough, Alan Faull, Craig Johnstone |
2008-04-15 |
$7,679,000 |
| 6989393 |
Ccr5 modulators benzimidazoles or benzotriazoles |
Jeremy Burrows, John Cumming |
2006-01-24 |
$34,538,000 |
| 6958350 |
Chemical compounds |
Stephen Brough, Matthew Perry, Brian Springthorpe |
2005-10-25 |
$12,058,000 |
| 6946478 |
Compounds |
Andrew Baxter, Stephen Brough, Nicholas Kindon, Bryan Roberts, Stephen Thom |
2005-09-20 |
$9,554,000 |
| 6903085 |
Substituted piperidine compounds useful as modulators of chemokine receptor activity |
Stephen Thom, Andrew Baxter, Nicholas Kindor, Brian Springthorpe, Matthew Perry +3 more |
2005-06-07 |
$11,041,000 |
| 6671800 |
Instructions for creating an extension data to create instances of an object with additional attributes without creating a new object type |
Robert Keith John Withey, Simon David Meldrum |
2003-12-30 |
$162,000 |
| 6566376 |
Diphenyl-piperidine derivative |
Andrew Baxter, Stephen Brough |
2003-05-20 |
$19,016,000 |
| 6562825 |
Piperazine derivatives as modulators of chemokine receptor activity |
Andrew Baxter, Stephen Brough, Nicholas Kindon, Bryan Roberts |
2003-05-13 |
$20,152,000 |
| 6518286 |
Compounds |
Andrew Baxter, Stephen Brough, Nicholas Kindon, Bryan Roberts, Stephen Thom |
2003-02-11 |
$5,073,000 |
| 6303613 |
Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals |
Alan Tinker |
2001-10-16 |
$8,674,000 |
